<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00591591</url>
  </required_header>
  <id_info>
    <org_study_id>R44NS040597</org_study_id>
    <secondary_id>2R44NS040597-04</secondary_id>
    <secondary_id>GRANT00130523</secondary_id>
    <secondary_id>RNS040597C</secondary_id>
    <nct_id>NCT00591591</nct_id>
  </id_info>
  <brief_title>Brain Oxygenation and Hemodynamics During Sleep in Obstructive Sleep Apnea Sufferers</brief_title>
  <acronym>NIRS-OSAS</acronym>
  <official_title>Absolute Near-Infrared Brain Oximeter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ISS, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Carle Foundation Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ISS, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this trial is to assess the performance of the OxiplexTS—an absolute
      near-infrared oximeter—as an instrument to measure brain oxygenation and hemodynamics in
      sleep medicine as well as in the broader field of cardiovascular/cerebrovascular diagnostics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Frequency domain near-infrared spectroscopy (NIRS) offers the advantage of performing safe,
      non-invasive, transcranial, quantitative measurements of brain oxygenation and hemodynamics
      in real-time. These characteristics make NIRS the ideal tool to study physiological and
      pathological processes of the brain, in settings ranging from research and diagnostic
      laboratories to intensive care units and operating rooms.

      Scientists recently developed the first commercially available absolute near-infrared
      oximeter, called OxiplexTS. This portable device will be used to study brain vascular
      autoregulatory responses (such as responses to hypoxia and hypercapnia) in persons with
      obstructive sleep apnea (OSA). These responses to allow for the assessment of brain vascular
      health. The OxiplexTS device will be beneficial in identifying persons at risk for
      cerebrovascular disease. Polysomnography (PSG), which is currently used to assess sleep
      disorders, gives important information on the function of different systems, however, it does
      not provide information on brain oxygenation and hemodynamics during sleep. The assessment of
      these factors, via NIRS, in persons with OSA is crucial because of the high prevalence of the
      disorder and the significant cardio/cerebrovascular health risk it represents.

      The specific aim of this trial is to make OxiplexTS a clinically usable instrument,
      especially for research and clinical diagnosis and monitoring of sleep disorders. An
      additional goal is to determine the usefulness of this instrument for providing measurements
      in various clinical situations including intensive care management or prolonged surgical
      procedures, such as cardiothoracic surgery that require critical information of brain
      oxygenation and hemodynamics. This trial emerges from previous phase I and phase II studies
      which determined the feasibility of using OxiplexTS to assess brain vascular autoregulatory
      responses to hypoxic stimuli.

      Approximately 300 participants will be recruited from a pool of healthy individuals,
      individuals with OSA, and volunteers undergoing overnight diagnostic or therapeutic PSG for
      suspected OSA.

      Participants will be divided into two groups: healthy controls and persons with OSA. Both
      groups will undergo standard overnight sleep study or PSG. In addition to the standard PSG
      (with or without Continuous Positive Airway Pressure (CPAP)), the study researchers will add
      the OxiplexTS—allowing them to assess brain oxygenation and hemodynamics during sleep. The
      hemodynamic patterns of the healthy controls will be compared to those of persons with OSA.
      Participants with OSA who undergo PSG/CPAP will be tested with the OxiplexTS, as well. Their
      PSG and PSG/CPAP data will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Oxygen Saturation in the Brain During Sleep</measure>
    <time_frame>6 hours of sleep</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxyhemoglobin Concentration in the Brain During Sleep</measure>
    <time_frame>6 hours of sleep</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Hemoglobin Concentration in the Brain During Sleep</measure>
    <time_frame>6 hours of sleep</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Deoxy-Hemoglobin Concentration in the Brain During Sleep</measure>
    <time_frame>6 hours of sleep</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Apnea Hypopnea Index (AHI is the Index of Severity That Combines Apneas and Hypopneas) Determined During the Routine Sleep Study</measure>
    <time_frame>6 hours of sleep</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">309</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>OSA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Persons with suspected obstructive sleep apnea (OSA) undergoning overnight sleep evaluation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Healthy controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OxiplexTS</intervention_name>
    <description>OxiplexTS is a Frequency Domain Near-Infrared Tissue oximeter which provides absolute values of tissue oxygenation in real time. It also provides physiological quantities of oxy, deoxy and total hemoglobin concentration, which form the basis for the functional measurement of brain hemodynamics. Both the control and OSA groups will undergo standard overnight sleep study (PSG). In addition to the standard PSG, with or without Continuous Positive Airway Pressure (CPAP), we will add the OxiplexTS, allowing us to assess brain oxygenation and hemodynamics during sleep. The hemodynamic patterns of the healthy controls will be compared to the OSA sufferers. Participants with OSA who undergo PSG/CPAP will be also tested with the OxiplexTS. Their PSGs and PSG/CPAP data will be compared.</description>
    <arm_group_label>OSA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy individuals (controls)

          -  Individuals undergoing overnight polysomnography foe suspected obstructive sleep apnea

        Exclusion Criteria:

          -  Documented severe cardiovascular disease.

          -  Documented cerebrovascular disease

          -  Documented cardiopulmonary disease

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonios Michalos, M.D., M.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>ISS, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California-Irvine Sleep Disorders Center, 101 The City Drive South, Bldg. 22C, 2nd Floor, Rt. 23</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford Sleep Disorders Clinic, Psychiatry Building, 401 Quarry Road</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center of Sleep and Ventilatory Disorders, University of Illinois Medical Center at Chicago, 2200 W Harrison</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carle Regional Sleep Disorders Center, Carle Foundation Hospital, 611 West Park Street</name>
      <address>
        <city>Urbana</city>
        <state>Illinois</state>
        <zip>61801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.iss.com</url>
    <description>company website</description>
  </link>
  <reference>
    <citation>Safonova LP, Michalos A , Wolf U, Wolf M, Mantulin WW, Hueber DM and Gratton E. Diminished cerebral circulatory autoregulation in obstructive sleep apnea investigated by near-infrared spectroscopy. Sleep Research on-line 2003; 5(4): 123-132, 2003.</citation>
  </reference>
  <reference>
    <citation>Safonova LP, Michalos A, Wolf U, Wolf M, Hueber DM, Choi JH, Gupta R, Polzonetti C, Mantulin WW, Gratton E. Age-correlated changes in cerebral hemodynamics assessed by near-infrared spectroscopy. Arch Gerontol Geriatr. 2004 Nov-Dec;39(3):207-25.</citation>
    <PMID>15381340</PMID>
  </reference>
  <reference>
    <citation>Olopade CO, Mensah E, Gupta R, Huo D, Picchietti DL, Gratton E, Michalos A. Noninvasive determination of brain tissue oxygenation during sleep in obstructive sleep apnea: a near-infrared spectroscopic approach. Sleep. 2007 Dec;30(12):1747-55.</citation>
    <PMID>18246984</PMID>
  </reference>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>January 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2008</study_first_posted>
  <results_first_submitted>September 22, 2010</results_first_submitted>
  <results_first_submitted_qc>February 15, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 11, 2011</results_first_posted>
  <last_update_submitted>March 10, 2011</last_update_submitted>
  <last_update_submitted_qc>March 10, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2011</last_update_posted>
  <responsible_party>
    <name_title>Antonios Michalos, M.D., M.S./Director of Medical Research, Principal Investigator</name_title>
    <organization>ISS, Inc.</organization>
  </responsible_party>
  <keyword>Obstructive Sleep Apnea Syndrome</keyword>
  <keyword>sleep disordered breathing</keyword>
  <keyword>polysomnography (psg)</keyword>
  <keyword>continuous positive airway pressure (cpap)</keyword>
  <keyword>brain vascular autoregulation</keyword>
  <keyword>brain tissue oxygenation</keyword>
  <keyword>near-infrared spectroscopy</keyword>
  <keyword>Obstructive Sleep Apnea</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>OSAS sufferers and Controls have been recruited an tested at:
Center of Sleep Disorders of the University of Illinois at Chicago.
Regional Sleep Disorders Center at Carle Foundation Hospital (Urbana,IL).
University of California-Irvine Medical Center-Center for Sleep Disorders (UCIMC)
Stanford University -Sleep Disorders Clinic</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Controls</title>
          <description>Healthy controls</description>
        </group>
        <group group_id="P2">
          <title>Obsructive Sleep Apnea Sufferers</title>
          <description>Patients undergoing sleep evaluation for suspected obstructive sleep apnea syndrome</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="176"/>
                <participants group_id="P2" count="133"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="165"/>
                <participants group_id="P2" count="94"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lack of Efficacy</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Controls</title>
          <description>Healthy controls</description>
        </group>
        <group group_id="B2">
          <title>Obsructive Sleep Apnea Sufferers</title>
          <description>Patients undergoing sleep evaluation for suspected obstructive sleep apnea syndrome</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="176"/>
            <count group_id="B2" value="133"/>
            <count group_id="B3" value="309"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="176"/>
                    <measurement group_id="B2" value="133"/>
                    <measurement group_id="B3" value="309"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.9" spread="10.15"/>
                    <measurement group_id="B2" value="41.7" spread="8.9"/>
                    <measurement group_id="B3" value="38.3" spread="9.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="111"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="176"/>
                    <measurement group_id="B2" value="133"/>
                    <measurement group_id="B3" value="309"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Oxygen Saturation in the Brain During Sleep</title>
        <time_frame>6 hours of sleep</time_frame>
        <population>Absolute Brain Oximetry: Quantitative Hemodynamic Responses of Brain During Sleep, in Healthy &amp; OSA Subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Controls</title>
            <description>Healthy controls</description>
          </group>
          <group group_id="O2">
            <title>Obsructive Sleep Apnea Sufferers</title>
            <description>Patients undergoing sleep evaluation for suspected obstructive sleep apnea syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Oxygen Saturation in the Brain During Sleep</title>
          <population>Absolute Brain Oximetry: Quantitative Hemodynamic Responses of Brain During Sleep, in Healthy &amp; OSA Subjects.</population>
          <units>Percentage of brain oxygen saturation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.462" spread="8.825"/>
                    <measurement group_id="O2" value="53.13" spread="11.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Oxyhemoglobin Concentration in the Brain During Sleep</title>
        <time_frame>6 hours of sleep</time_frame>
        <population>Absolute Brain Oximetry: Quantitative Hemodynamic Responses of Brain During Sleep, in Healthy &amp; OSA Subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Controls</title>
            <description>Healthy controls</description>
          </group>
          <group group_id="O2">
            <title>Obsructive Sleep Apnea Sufferers</title>
            <description>Patients undergoing sleep evaluation for suspected obstructive sleep apnea syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Oxyhemoglobin Concentration in the Brain During Sleep</title>
          <population>Absolute Brain Oximetry: Quantitative Hemodynamic Responses of Brain During Sleep, in Healthy &amp; OSA Subjects.</population>
          <units>µM</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.82" spread="7.81"/>
                    <measurement group_id="O2" value="18.36" spread="7.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Total Hemoglobin Concentration in the Brain During Sleep</title>
        <time_frame>6 hours of sleep</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Controls</title>
            <description>Healthy controls</description>
          </group>
          <group group_id="O2">
            <title>Obsructive Sleep Apnea Sufferers</title>
            <description>Patients undergoing sleep evaluation for suspected obstructive sleep apnea syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Total Hemoglobin Concentration in the Brain During Sleep</title>
          <units>µM</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.38" spread="11.72"/>
                    <measurement group_id="O2" value="33.71" spread="11.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Deoxy-Hemoglobin Concentration in the Brain During Sleep</title>
        <time_frame>6 hours of sleep</time_frame>
        <population>Absolute Brain Oximetry: Quantitative Hemodynamic Responses of Brain During Sleep, in Healthy &amp; OSA Subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Controls</title>
            <description>Healthy controls</description>
          </group>
          <group group_id="O2">
            <title>Obsructive Sleep Apnea Sufferers</title>
            <description>Patients undergoing sleep evaluation for suspected obstructive sleep apnea syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Deoxy-Hemoglobin Concentration in the Brain During Sleep</title>
          <population>Absolute Brain Oximetry: Quantitative Hemodynamic Responses of Brain During Sleep, in Healthy &amp; OSA Subjects.</population>
          <units>µM</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.82" spread="6.73"/>
                    <measurement group_id="O2" value="15.41" spread="4.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Apnea Hypopnea Index (AHI is the Index of Severity That Combines Apneas and Hypopneas) Determined During the Routine Sleep Study</title>
        <time_frame>6 hours of sleep</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Controls</title>
            <description>Healthy controls</description>
          </group>
          <group group_id="O2">
            <title>Obsructive Sleep Apnea Sufferers</title>
            <description>Patients undergoing sleep evaluation for suspected obstructive sleep apnea syndrome</description>
          </group>
        </group_list>
        <measure>
          <title>Apnea Hypopnea Index (AHI is the Index of Severity That Combines Apneas and Hypopneas) Determined During the Routine Sleep Study</title>
          <units>Number of apnea/hypopnea per sleep hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="176"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.78" spread="2.41"/>
                    <measurement group_id="O2" value="42.4" spread="32.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Controls</title>
          <description>Healthy controls</description>
        </group>
        <group group_id="E2">
          <title>Obsructive Sleep Apnea Sufferers</title>
          <description>Patients undergoing sleep evaluation for suspected obstructive sleep apnea syndrome</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="133"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Antonios Michalos</name_or_title>
      <organization>ISS, Inc., Champaign Illinois</organization>
      <phone>217-359-8681</phone>
      <email>antonios.michalos@iss.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

